ADMA ADMA BIOLOGICS, INC.: institutional ownership and insider trading
357 funds reported holding $2.22B of ADMA BIOLOGICS, INC. in their latest 13F filings; in Q2 2026 funds net sold $112M, with 49 new positions and 85 funds selling out; over the last 12 months insiders bought $468K and sold $1.57M on the open market; over its last four quarters it reported revenue of $512M and net income of $169M.
ADMA revenue and earnings
- Quarter ended Jun 30, 2026: revenue $124M, net income $37.8M, EPS 0.16
- Quarter ended Mar 31, 2026: revenue $114M, net income $45.3M, EPS 0.19
- Quarter ended Dec 31, 2025: revenue $139M, net income $49.4M, EPS 0.20
- Quarter ended Sep 30, 2025: revenue $134M, net income $36.4M, EPS 0.15
Famous investors holding ADMA
- Stanley Druckenmiller (Duquesne Family Office): $23.3M, 0.5% of the portfolio
- Terry Smith (Fundsmith): $13.8M, 0.1% of the portfolio
- D. E. Shaw (D. E. Shaw & Co.): $44.1M, 0.0% of the portfolio
- Two Sigma (Two Sigma Investments): $16.9M, 0.0% of the portfolio
- Renaissance Technologies (Renaissance Technologies): $5.46M, 0.0% of the portfolio
- Ray Dalio (Bridgewater Associates): $3.36M, 0.0% of the portfolio
- Ken Griffin (Citadel Advisors): $13.6M, 0.0% of the portfolio
- Izzy Englander (Millennium Management): $9.66M, 0.0% of the portfolio
Largest institutional holders of ADMA
- VANGUARD GROUP INC — $380M
- BlackRock, Inc. (BLK) — $321M
- STATE STREET CORP (STT, STT-PG) — $143M
- VANGUARD CAPITAL MANAGEMENT LLC — $84.6M
- VANGUARD PORTFOLIO MANAGEMENT LLC — $84.4M
- Rubric Capital Management LP — $78.2M
- Nuveen Asset Management, LLC — $78.1M
- Capital Research Global Investors — $73.3M
- FIRST TRUST ADVISORS LP — $65.3M
- GEODE CAPITAL MANAGEMENT, LLC — $50.7M
Recent ADMA insider trades
- May 27, 2026: Grossman Jerrold B bought 6,400 shares ($50.6K)
- May 12, 2026: Grossman Jerrold B bought 12,500 shares ($100K)
- May 11, 2026: Grossman Jerrold B bought 12,500 shares ($100K)
- Mar 16, 2026: Grossman Adam S sold 21,000 shares ($318K)
5%+ owners
- STATE STREET CORPORATION: 7.4% (Schedule 13G, filed Aug 7, 2026)
- Vanguard Capital Management: 5.1% (Schedule 13G, filed Apr 29, 2026)
Who owns the most ADMA stock?
The largest institutional holders of ADMA BIOLOGICS, INC. in the latest 13F filings are VANGUARD GROUP INC ($380M), BlackRock, Inc. (BLK) ($321M), STATE STREET CORP (STT, STT-PG) ($143M).
Are insiders buying or selling ADMA?
Over the last 12 months insiders bought $468K and sold $1.57M of ADMA BIOLOGICS, INC. stock on the open market (SEC Form 4).
Which famous investors own ADMA?
Stanley Druckenmiller, Terry Smith, D. E. Shaw, Two Sigma, Renaissance Technologies.
What was ADMA's revenue last quarter?
ADMA BIOLOGICS, INC. reported revenue of $124M for the quarter ended June 30, 2026, with net income of $37.8M.
Which ETFs hold ADMA?
18 ETFs and mutual funds hold it among their top 100 positions, including FBT, XBI, IBB, LABU.